You are here: Home Newsroom Features Walgreens Boots Alliance Publishes 2018 Corporate Social Responsibility Report

Walgreens Boots Alliance Publishes 2018 Corporate Social Responsibility Report

12 February 2019
Feature Brand

Walgreens Boots Alliance today published its 2018 Corporate Social Responsibility (CSR) Report covering the company’s progress during the fiscal year ended 31 August 2018.


  • Helped to provide life-changing vitamins and minerals to more than 160 million children and  women through a CSR partnership with Vitamin Angels
  • Helped to provide more than 34 million lifesaving vaccines to children in the developing world through a CSR partnership with the UN Foundation
  • Announces new and expanded UK CSR partnerships with The Prince’s Trust, WE

The report, which can be read in full here, showcases the company’s global sustainability initiatives to prevent opioid abuse, support cancer patients and their families and address malnutrition and other health issues in communities around the world.

WBA’s CSR strategy is largely focused on health care initiatives, particularly access and affordability, due to the nature of the company’s pharmacy and wellbeing business. Working with partner organizations the company has helped provide life-changing vitamins and minerals to more than 160 million children and women, and more than 34 million lifesaving vaccines to children in the developing world.

“As a pharmacy-led global company we have a tremendous opportunity to change the world for better. Through our health-centered initiatives we have had a positive impact on millions of people in the communities we serve and in underserved areas across the planet,” said Ornella Barra, Walgreens Boots Alliance co-chief operating officer and chairman of the Corporate Social Responsibility Committee. “We believe that we can drive business results while benefitting society and that is why we have embedded CSR in everything we do.”

The report was launched today at the Boots UK support office in Nottingham, coinciding with the celebration of 170 years since Boots was founded here. Over this time Boots UK has pioneered CSR work in many areas, such as product sustainability, community partnerships and sustainability reporting.

Partnerships have been a core WBA strategy for delivering health benefits for communities, customers and our employees. In keeping with this approach, Boots UK also announced today new and expanded CSR partnerships:

  • A new partnership with The Prince’s Trust aims to increase employment opportunities for young people across the UK, by supporting them todevelop skills for the workplace and by providing in-store opportunities.
  • An extension of its partnership with WE – a family of organizations that make doing good, doable - aims to help a generation of young people in Nottingham fulfill their potential. The UK WE Schools program empowers young people to develop their personal wellbeing and workplace readiness through social action. In November 2019, Boots and WE will host the first WE Day Community Nottingham youth celebration event.

WBA achieved a number of sustainability milestones in the 12 months that ended August 31, 2018. Highlights in the company’s 2018 CSR Report include:

Opioid abuse prevention: Walgreens expanded its efforts to combat overdose-related deaths. Between May 2016 and August 2018, Walgreens safe medication disposal kiosk program collected and safely disposed more than 410 tons (372 metric tonnes) of unused and unwanted medication to curb the abuse of prescription drugs.

Dementia awareness: Boots UK continued to work with Dementia Friends – an Alzheimer’s Society initiative to change people’s perceptions and understanding of dementia. Boots has helped to create more than 38,000 Dementia Friends, people with an understanding of what it can be like to live with dementia. There is at least one Dementia Friend in every Boots store in Great Britain, to help people who shop at Boots stores feel safe, calm and comfortable.

Cancer programs: We extended our partnership with the European Organisation for Research and Treatment of Cancer (EORTC) with a commitment to raise €5 million by 2023 to further advance our joint goals of providing better treatment and quality of life for people with cancer, in addition to the more than €5 million raised previously. Also, this year Boots UK is celebrating its 10-year anniversary of working with Macmillan Cancer Support. Boots UK employees and customers have raised more than £16.6 million ($25.1 million) for Macmillan Cancer Support as of August 31, 2018.

Emissions reduction and waste initiatives: WBA has reduced its carbon footprint by 15.3 percent since fiscal 2016, the baseline year for the company’s CSR performance data. In fiscal 2018 Walgreens distribution facilities in the U.S. and Puerto Rico diverted 93 percent of waste from landfills. Walgreens also diverted more than 3.4 million pounds of safe and unused toiletries, food and household items from landfills by donating the items to Feeding America.

Product transparency: WBA has implemented a chemicals management program to assess and restrict the use of certain chemicals and ingredients in products it sells and provide greater transparency for consumers.

The WBA 2018 CSR Report was prepared in accordance with the GRI Standards: Core option. The GRI Standards are the world’s most widely used set of sustainability reporting standards. The full report is available at To learn more about WBA and sustainability, connect with the company on WBA Linkedin.


What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.



Read the views of our team members at Boots, who are experts in their field. Find out what they think about the most important issues of the day – from healthcare equality to sustainability.


Media Resources

A you are a journalist looking for information and resources about Boot? Visit our media resources hub to access images, reports, spokespeople and videos.


Boots is the UK’s leading health and beauty retailer with over 52,000 team members and 2,100 stores, ranging from local community pharmacies to large destination health and beauty stores.*

Boots serves its customers and patients for life as the leading provider of healthcare on the high street and the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.

2024 marks Boots’ 175th anniversary year. Founder John Boot opened a herbalist store in Nottingham in 1849 to offer an affordable alternative to traditional medicines. His son Jesse expanded the business to become a modern retailer and the biggest chemist in Britain. Throughout its history, Boots has listened, learned and innovated, and it continues to challenge itself to improve its products and services every day.

Boots is part of Walgreens Boots Alliance, which is a global leader in pharmacy-led, health and wellbeing retail.  More company information is available on

*Figures accurate as of 30 November 2023